← Back to Search
Cell-Mediated Release Of Nanoparticles As A Preferential Option For Future Treatment Of Melanoma
A. Chillà, F. Margheri, A. Biagioni, T. Del Rosso, G. Fibbi, M. Del Rosso, Anna Laurenzana
Published 2020 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Targeted and immune therapies have unquestionably improved the prognosis of melanoma patients. However the treatment of this neoplasm still requires approaches with a higher therapeutic index, in order to reduce shortcomings related to toxic effects and aspecific targeting. This means developing therapeutic tools derived with high affinity molecules for tumor components differentially expressed in melanoma cells with respect to their normal counterpart. Nanomedicine has sought to address this problem owing to the high modulability of nanoparticles. This approach exploits not only the enhanced permeability and retention effect typical of the tumor microenvironment (passive targeting), but also the use of specific “molecular antennas” that recognize some tumor-overexpressed molecules (active targeting). This line of research has given rise to the so-called “smart nanoparticles,” some of which have already passed the preclinical phase and are under clinical trials in melanoma patients. To further improve nanoparticles partition within tumors, for some years now a line of thought is exploiting the molecular systems that regulate the innate tumor-homing activity of platelets, granulocytes, monocytes/macrophages, stem cells, endothelial-colony-forming cells, and red blood cells loaded with nanoparticles. This new vision springs from the results obtained with some of these cells in regenerative medicine, an approach called “cell therapy.” This review takes into consideration the advantages of cell therapy as the only one capable of overcoming the limits of targeting imposed by the increased interstitial pressure of tumors.
This paper references
Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
D. Wang (2018)
Neutrophils in cancer: neutral no more
S. Coffelt (2016)
Microlymphatics and lymph flow.
G. W. Schmid-Schönbein (1990)
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy.
Dafeng Chu (2016)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
H. Maeda (2018)
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Kimberley M Laginha (2005)
A macrophage-nanozyme delivery system for Parkinson's disease.
E. Batrakova (2007)
Platelets and angiogenesis in malignancy.
E. Sierko (2004)
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
S. Momi (2009)
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae.
F. Margheri (2011)
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.
M. Loebinger (2009)
Contribution of platelets to tumour metastasis
Laurie J. Gay (2011)
Melanoma treatment in review
B. Domingues (2018)
Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection.
Az Alddien Natfji (2017)
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.
M. Yoder (2007)
Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis
K. Carbajal (2010)
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
J. Bagó (2016)
Working hypothesis to redefine endothelial progenitor cells
D. Prater (2007)
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells.
R. Jones (2017)
How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
A. Poggi (2018)
The role of neutrophils in cancer
R. Grecian (2018)
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
N. Tanaka (2017)
Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery
D. Sun (2019)
Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model
Matthew T. Basel (2012)
Prognostic value of neutrophil-to-lymphocyte ratio in melanoma. Evidence from a PRISMA-compliant meta-analysis. Medicine (Baltimore
Y. Ding (2018)
Intracellular dis-tribution of macrophage migration inhibitory factor predicts the prognosis ofpatients with adenocarcinoma of the lung. Cancer
A Kamimura (2000)
Neural stem cell therapy for cancer.
J. Bagó (2016)
Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung
A. Kamimura (2000)
Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation
E. Chambers (2007)
NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation.
C. Thålin (2016)
Tumor-Associated Neutrophils in Cancer: Going Pro
L. Wu (2019)
A Simple Method to Isolate and Expand Human Umbilical Cord Derived Mesenchymal Stem Cells: Using Explant Method and Umbilical Cord Blood Serum
G. Hassan (2017)
Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes
Ursula Altanerova (2019)
Induction of pluripotent stem
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
E. Chambers (2004)
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor
A. Blann (2001)
Neural Stem Cells: Generating and Regenerating the Brain
F. Gage (2013)
Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Y. Guo (2015)
Prognostic value of neutrophil - to - lymphocyte ratio in melanoma . Evidence from a PRISMA - compliant meta - analysis
Y. Ding (2018)
Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma
K. Meyer-Siegler (2002)
Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery.
Xinglu Huang (2013)
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.
C. Martin (2003)
Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors
S. Lourenco (2015)
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health
N. Sacchi (2008)
Tumor targeting via EPR: Strategies to enhance patient responses.
Susanne K Golombek (2018)
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.
H. M. Verheul (2000)
Nanoparticles in the clinic: An update
Aaron C. Anselmo (2019)
Recent Advances in Endothelial Progenitor Cells Toward Their Use in Clinical Translation
C. Keighron (2018)
Endothelial Progenitors: A Consensus Statement on Nomenclature
Reinhold J Medina (2017)
Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumor angiogenesis.
K. Bieback (2013)
Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis.
M. Hölzel (2016)
Potential role of platelets in the pathogenesis of tumor metastasis.
P. Mehta (1984)
Cord blood endothelial progenitor cells as therapeutic and imaging probes.
B. Janic (2012)
Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.
Aaron C. Anselmo (2014)
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
P. Jurasz (2004)
The hypoxic tumour microenvironment
V. Petrova (2018)
Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
M. Tomiyasu (2002)
Protein profiling identified key chemokines that regulate the maintenance of human pluripotent stem cells
Zongmin Jiang (2017)
Cancer statistics, 2014
R. Siegel (2014)
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells.
Keishi Otsu (2009)
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities
R. Medina (2009)
Nanoparticle-mediated drug delivery for treating melanoma.
Vaibhav Mundra (2015)
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions.
O. McCarty (2000)
Pathophisiology of Edema Formation. Capillary Fluid Exchange: Regulation, Functions, and Pathology; Morgan&Claypool Life Sciences
J. Scallan (2010)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ningbo Hao (2012)
The prognostic landscape of genes and infiltrating immune cells across human cancers
A. Gentles (2015)
Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and Dogs
A. Gabizon (2004)
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
K. J. Mahasa (2020)
Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Yanna Cui (2016)
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
M. Shevtsov (2018)
The tumor microenvironment at a glance
F. Balkwill (2012)
Renal toxicities of chemotherapy.
M. D. de Jonge (2006)
Priming of neutrophils toward NETosis promotes tumor growth
Mélanie Demers (2016)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Cellular Cyborgs: On the Precipice of a Drug Delivery Revolution.
S. Ding (2018)
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.
S. Goff (2016)
Current state of melanoma diagnosis and treatment
L. Davis (2019)
Pathology: Cancer cells compress intratumour vessels
T. Padera (2004)
Openings between defective endothelial cells explain tumor vessel leakiness.
H. Hashizume (2000)
Roles of neutrophils in cancer growth and progression
M. R. Galdiero (2018)
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A “cellular stove” approach to the photoablation of melanoma
G. Margheri (2016)
PLATELET PHAGOCYTOSIS AND AGGREGATION
H. Movat (1965)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis
Katrin Echtler (2017)
Platelet-Like Gold Nanostars for Cancer Therapy: The Ability to Treat Cancer and Evade Immune Reactions
Min Woo Kim (2020)
Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas
Wanlu Du (2017)
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.
Luise Erpenbeck (2010)
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy
H. Hamada (2005)
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents.
H. Mirzaei (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier (2016)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu (2012)
Cell-based drug delivery devices using phagocytosis-resistant backpacks.
N. Doshi (2011)
Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.
R. S. Rachakatla (2010)
Differential immunomodulating effects of pegylated liposomal doxorubicin nanoparticles on human macrophages.
Chia-Yuan Liu (2012)
A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors.
M. Choi (2007)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay (2019)
Melanoma treatment: from conventional to nanotechnology
Harshita Mishra (2018)
Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
M. Wang (2018)
Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine
D. Lombardo (2019)
Leukocytes as carriers for targeted cancer drug delivery
Michael J Mitchell (2015)
The scope of nanoparticle therapies for future metastatic melanoma treatment.
F. B. Bombelli (2014)
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling
N. Wang (2018)
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
M. Gnecchi (2009)
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
T. Chan (2016)
CXCL5 as Regulator of Neutrophil Function in Cutaneous Melanoma.
A. Forsthuber (2019)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
M. Dudley (2005)
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Miles A. Miller (2015)
Cancer drug delivery in the nano era: An overview and perspectives
Z. Li (2017)
Chemokines in cancer.
M. Frederick (2001)
Platelet activation and platelet lipid composition in pulmonary cancer.
D. Prisco (1995)
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma).
P. Mannucci (1989)
Endothelial Progenitor Cells as Shuttle of Anticancer Agents.
A. Laurenzana (2016)
Mesenchymal Stem Cells Aggregate and Deliver Gold Nanoparticles to Tumors for Photothermal Therapy.
S. Kang (2015)
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.
J. Belperio (2002)
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
Kazutoshi Takahashi (2006)
CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis.
A. Soler-Cardona (2018)
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma
Gwi-Moon Seo (2011)
Platelet count correlates with stage and predicts survival in melanoma
S. Rachidi (2019)
Releasing pressure in tumors: what do we know so far and where do we go from here? A review.
A. N. Ariffin (2014)
Platelets and cancer metastasis: more than an epiphenomenon.
K. Honn (1992)
Capillary Fluid Exchange: Regulation, Functions, and Pathology
Joshua P. Scallan (2010)
CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow.
K. J. Eash (2010)
Neutrophil mobilization and clearance in the bone marrow
R. C. Furze (2008)
It is finally time for adjuvant therapy in melanoma.
S. Napolitano (2018)
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.
D. Ingram (2004)
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
L. Qiao (2008)
Biodistribution and Pharmacokinetic Analysis of Paclitaxel and Ceramide Administered in Multifunctional Polymer-Blend Nanoparticles in Drug Resistant Breast Cancer Model
Lilian E van Vlerken (2008)
CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
Natnaree Siriwon (2018)
Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.
Aaron C. Anselmo (2013)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm (2016)
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
R. J. Phillips (2003)
Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
R. Jain (1988)
P-selectin promotes neutrophil extracellular trap formation in mice.
J. Etulain (2015)
Amelio, I. The hypoxic tumour microenvironment
V Petrova (2018)
Using gold nanoparticles in diagnosis and treatment of melanoma cancer
S. Bagheri (2018)
Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.
Y. Zhao (2011)
Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
B. Sharma (2013)
Endothelial progenitor cells--an evolving story.
J. Pearson (2010)
Increased platelet distribution width predicts poor prognosis in melanoma patients
N. Li (2017)
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
K. Harrington (2001)
Cancer nanomedicine: Is targeting our target?
T. Lammers (2016)
Current Understanding in Neutrophil Differentiation and Heterogeneity
Chang-Won Hong (2017)
Cancer cells compress intratumor vessels: Pressure from proliferating cells impedes transport of therapeutic drugs into tumors
T. P. Padera (2004)
Expression of Macrophage Migration Inhibitory Factor Relates to Survival in High-grade Osteosarcoma
I. Han (2008)
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme
A. Laurenzana (2014)
Activation of Signal Transducers and Activators of Transcription 3 and Focal Adhesion Kinase by Stromal Cell‐Derived Factor 1 Is Required for Migration of Human Mesenchymal Stem Cells in Response to Tumor Cell‐Conditioned Medium
H. Gao (2009)
Tumor-associated neutrophils: friend or foe?
Z. Fridlender (2012)
Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma
P. Xu (2017)
This paper is referenced by
Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis
Maria Beatrice Arasi (2020)